Phase 1 study of mebendazole therapy for refractory/progressive or recurrent pediatric brain tumors.

Phan P, Stapleton SL, Riggins GJ, Koldobskiy MA, Raabe E, Cohen KJ

DOI: 10.1093/nop/npaf060
Published: 2025 Dec
Container: Neuro-oncology practice
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/nop/npaf060,
  title = {Phase 1 study of mebendazole therapy for refractory/progressive or recurrent pediatric brain tumors.},
  author = {Phan P and Stapleton SL and Riggins GJ and Koldobskiy MA and Raabe E and Cohen KJ},
  year = {2025},
  journal = {Neuro-oncology practice},
  doi = {10.1093/nop/npaf060},
  url = {https://doi.org/10.1093/nop/npaf060}
}

RIS

TY  - JOUR
TI  - Phase 1 study of mebendazole therapy for refractory/progressive or recurrent pediatric brain tumors.
AU  - Phan P
AU  - Stapleton SL
AU  - Riggins GJ
AU  - Koldobskiy MA
AU  - Raabe E
AU  - Cohen KJ
PY  - 2025
JO  - Neuro-oncology practice
DO  - 10.1093/nop/npaf060
UR  - https://doi.org/10.1093/nop/npaf060
ER  -

APA

P, P., SL, S., GJ, R., MA, K., E, R., & KJ, C. (2025). Phase 1 study of mebendazole therapy for refractory/progressive or recurrent pediatric brain tumors.. Neuro-oncology practice. https://doi.org/10.1093/nop/npaf060

Source records

pubmed · retrieved 2026-09-25T07:51:29.580Z